Position in ALLO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$383,653
+$249,519 QoQ
Shares Held
157,235
+60.6% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 2%
Shared 33%
None 65%
Common Shares in ALLO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Cerity Partners LLC holds $355,640,511 across 116 Biotechnology names. ALLO ranks #57 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
296,654 | $132,467,876 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
43,972 | $33,974,525 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
731,689 | $29,494,383 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
349,137 | $22,564,723 | |
| 5 | INCY |
Incyte Corp
|
226,501 | $21,318,272 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
263,389 | $14,878,843 | |
| 7 | EXEL |
Exelixis, Inc.
|
313,945 | $13,465,100 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
45,746 | $8,648,280 |
All Filings in ALLO
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $383,653 | 157,235 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $134,134 | 97,909 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $578,747 | 466,732 | Shares | Other | 2025-10-22 | |
| 2025-06-30 | $452,301 | 400,267 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $555,419 | 380,424 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $825,134 | 387,387 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $1,210,669 | 432,382 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,006,909 | 432,150 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,896,035 | 424,169 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,661,435 | 517,581 | Shares | Sole | 2024-01-26 | |
| 2023-06-30 | $2,972,557 | 598,100 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,964,266 | 600,054 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,706,407 | 589,254 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $6,808,590 | 630,425 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,851,559 | 601,014 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $6,386,592 | 701,053 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $10,494,519 | 703,386 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $10,229,936 | 398,052 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $10,435,964 | 400,152 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $14,176,550 | 401,602 | Shares | Sole | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||